INB03 increases uptake of deruxtecan, the immunotoxin associated with trastuzumab deruxtecan (T-DXd, ENHERTU®), in models of resistant MUC4 expressing HER2 positive breast cancer and increases the ...
RALEIGH, NC - August 23, 2011- Ajinomoto AminoScience LLC (http://www.ajiaminoscience.com/Default.aspx) (AAS) today announced the availability of a case study ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results